Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory?

Ana M Fernández-OrtizAna M OrtizSilvia PérezEsther ToledanoLydia AbásoloMiguel A González-GaySantos CastañedaIsidoro González-Alvaro

Published in: Arthritis research & therapy (2020)

High-disease activity in EA patients results in changes in the HDL-C and oxLDL-C levels, which in turn may contribute to the increased risk of CV disease observed in these patients.

Keyphrases

disease activity
rheumatoid arthritis
systemic lupus erythematosus
end stage renal disease
rheumatoid arthritis patients
newly diagnosed
ejection fraction
ankylosing spondylitis
chronic kidney disease
low density lipoprotein
prognostic factors
juvenile idiopathic arthritis
patient reported outcomes